Sartorius Aktiengesellschaft (ETR:SRT) Stock Price Up 2.2% - Time to Buy?

Key Points

• Sartorius Aktiengesellschaft saw its share price increase by 2.2%, trading at approximately €173.60 ($201.86) after reaching a high of €174.00 ($202.33).
• The company has a debt-to-equity ratio of 169.56 and a market capitalization of $13.49 billion, indicating substantial leverage.
• Sartorius Aktiengesellschaft specializes in bioprocess solutions and lab products, offering a range of bioreactors and fluid management products.

Sartorius Aktiengesellschaft (ETR:SRT - )'s share price rose 2.2% on Thursday . The company traded as high as €174.00 ($202.33) and last traded at €173.60 ($201.86). Approximately 2,251 shares changed hands during mid-day trading, The stock had previously closed at €169.80 ($197.44).

Sartorius Aktiengesellschaft Price Performance

The company has a debt-to-equity ratio of 169.56, a current ratio of 2.02 and a quick ratio of 0.36. The stock has a market cap of $13.49 billion, a price-to-earnings ratio of 87.32, a price-to-earnings-growth ratio of 2.28 and a beta of 0.93. The business's 50-day simple moving average is €164.89 and its two-hundred day simple moving average is €169.18.

About Sartorius Aktiengesellschaft

Sartorius Aktiengesellschaft provides bioprocess solutions and lab products and services in the United States and internationally. The company offers multi-parallel, benchtop, single-use, stainless steel, cell culture, rocking motion, and microbial bioreactors, and software apps for bioreactors and cell culture shake flask; fermenters; cell culture media products; cellcelector flex, incubator flowbox, nanowell arrays, and capillaries and tips; fluid management products; microbiology products; and Ultrafiltration membrane filters, glass and quartz microfiber filters, clarification, syringeless and in-line filters, lab chromatography, and filters and blotting papers.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.